[HTML][HTML] Global epidemiology of vasculitis

RA Watts, G Hatemi, JC Burns… - Nature reviews …, 2022 - nature.com
The many forms of vasculitis are characterized by inflammation of blood vessels, leading to
potentially long-term sequelae including vision loss, aneurysm formation and kidney failure …

[HTML][HTML] New onset of autoimmune diseases following COVID-19 diagnosis

AE Gracia-Ramos, E Martin-Nares… - Cells, 2021 - mdpi.com
There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

C Ponte, PC Grayson, JC Robson, R Suppiah… - Annals of the …, 2022 - ard.bmj.com
Objective To develop and validate updated classification criteria for giant cell arteritis (GCA).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

PC Grayson, C Ponte, R Suppiah… - Arthritis & …, 2022 - Wiley Online Library
Objective To develop and validate new classification criteria for Takayasu arteritis (TAK).
Methods Patients with vasculitis or comparator diseases were recruited into an international …

[HTML][HTML] Trial of tocilizumab in giant-cell arteritis

JH Stone, K Tuckwell, S Dimonaco… - … England Journal of …, 2017 - Mass Medical Soc
Background Giant-cell arteritis commonly relapses when glucocorticoids are tapered, and
the prolonged use of glucocorticoids is associated with side effects. The effect of the …

[HTML][HTML] Editor's choice–management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS)

V Riambau, D Böckler, J Brunkwall, P Cao… - European Journal of …, 2017 - Elsevier
1.1. Purpose The European Society for Vascular Surgery (ESVS) appointed the Descending
Thoracic Aorta (DTA) Writing Committee (WC) to produce the current clinical practice …

[PDF][PDF] 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

R Erbel, V Aboyans, C Boileau… - Kardiologia Polska …, 2014 - journals.viamedica.pl
Poziom B Dane pochodzące z jednej randomizowanej próby klinicznej lub dużych badań
nierandomizowanych Poziom C Uzgodniona opinia ekspertów i/lub dane pochodzące z …

Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

PM Villiger, S Adler, S Kuchen, F Wermelinger, D Dan… - The Lancet, 2016 - thelancet.com
Background Giant cell arteritis is an immune-mediated disease of medium and large-sized
arteries that affects mostly people older than 50 years of age. Treatment with glucocorticoids …

Polymyalgia rheumatica and giant cell arteritis: a systematic review

F Buttgereit, C Dejaco, EL Matteson, B Dasgupta - Jama, 2016 - jamanetwork.com
Importance Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related
inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and …

Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides

JC Jennette - Clinical and experimental nephrology, 2013 - Springer
The nomenclature and classification of vasculitis has been difficult and controversial for
many decades. This is problematic both for research on vasculitis as well as clinical care of …